^
FGFR2 rearrangement
Cholangiocarcinoma
FGFR2 fusion
Cholangiocarcinoma
NTRK3 fusion
Cholangiocarcinoma
NTRK2 fusion
Cholangiocarcinoma
NTRK1 fusion
Cholangiocarcinoma
FGFR2 mutation
Cholangiocarcinoma
FGFR2 rearrangement
Cholangiocarcinoma
FGFR2 fusion
Cholangiocarcinoma
No biomarker
Gallbladder Cancer
No biomarker
Gallbladder Cancer
No biomarker
Gallbladder Cancer
IDH1 mutation
Cholangiocarcinoma
No biomarker
Biliary Tract Cancer
No biomarker
Gallbladder Cancer
No biomarker
Biliary Tract Cancer
No biomarker
Gallbladder Cancer
No biomarker
Gallbladder Cancer
No biomarker
Gallbladder Cancer
No biomarker
Biliary Tract Cancer
No biomarker
Cholangiocarcinoma
No biomarker
Gallbladder Cancer
No biomarker
Gallbladder Cancer
No biomarker
Gallbladder Cancer
No biomarker
Gallbladder Cancer
No biomarker
Cholangiocarcinoma
No biomarker
Biliary Tract Cancer
No biomarker
Biliary Tract Cancer
No biomarker
Biliary Tract Cancer
No biomarker
Biliary Tract Cancer
BRAF V600E
Biliary Tract Cancer
MSI-H/dMMR
Biliary Tract Cancer
NTRK3 fusion
Biliary Tract Cancer
NTRK2 fusion
Biliary Tract Cancer
NTRK3 fusion
Biliary Tract Cancer
NTRK2 fusion
Biliary Tract Cancer
NTRK1 fusion
Biliary Tract Cancer
NTRK1 fusion
Biliary Tract Cancer
No biomarker
Biliary Tract Cancer
No biomarker
Biliary Tract Cancer
No biomarker
Biliary Tract Cancer
No biomarker
Biliary Tract Cancer
BRAF V600E
Biliary Tract Cancer
No biomarker
Biliary Tract Cancer
No biomarker
Cholangiocarcinoma
HER-2 expression
Biliary Tract Cancer
FGFR2 rearrangement
Cholangiocarcinoma
FGFR2 fusion
Cholangiocarcinoma
HER-2 expression
Cholangiocarcinoma
RET fusion
Cholangiocarcinoma
MSI-H/dMMR
Gallbladder Cancer
BRCA2 mutation
Cholangiocarcinoma
BRCA1 mutation
Cholangiocarcinoma
HER-2 overexpression
Gallbladder Cancer
FGFR3 mutation
Cholangiocarcinoma
FGFR2 mutation
Cholangiocarcinoma
MSI-H/dMMR
Gallbladder Cancer
PD-L1 expression
Biliary Tract Cancer
BRAF V600
Cholangiocarcinoma
MSI-H/dMMR
Cholangiocarcinoma
PD-L1 expression
Biliary Tract Cancer
BRAF V600E
Cholangiocarcinoma
NTRK2 fusion
Cholangiocarcinoma
NTRK3 fusion
Cholangiocarcinoma
NTRK1 fusion
Cholangiocarcinoma
HER-2 positive
Biliary Tract Cancer
BRAF V600E
Biliary Tract Cancer
BRCA2 mutation
Biliary Tract Cancer
ATM mutation
Biliary Tract Cancer
FGFR2 translocation
Cholangiocarcinoma
FGFR2 fusion
Cholangiocarcinoma
FGFR2 mutation
Cholangiocarcinoma
FGFR2 mutation
Cholangiocarcinoma
FGFR2 amplification
Cholangiocarcinoma
PD-L1 expression
Biliary Tract Cancer
FGFR2 mutation
Cholangiocarcinoma
IDH2 mutation
Cholangiocarcinoma
IDH1 R132C
Cholangiocarcinoma
PD-L1 expression
Biliary Tract Cancer
IDH1 mutation
Cholangiocarcinoma
HER-2 overexpression
Biliary Tract Cancer
HER-2 mutation
Biliary Tract Cancer
MET amplification
Gallbladder Cancer
ERBB3 mutation
Gallbladder Cancer
HER-2 amplification
Gallbladder Cancer
HER-2 amplification
Gallbladder Cancer
HER-2 amplification
Gallbladder Cancer
ATM mutation
Biliary Tract Cancer
HER-2 amplification
Cholangiocarcinoma
DDR
Cholangiocarcinoma
PD-L1 expression
Cholangiocarcinoma
ERBB3 mutation
Gallbladder Cancer
ERBB3 amplification
Gallbladder Cancer
ERBB3 amplification + ERBB3 mutation
Gallbladder Cancer
HER-2 expression
Biliary Tract Cancer
ARID1A mutation
Cholangiocarcinoma
FGFR2 fusion
Cholangiocarcinoma
FGFR3-TACC3 fusion
Gallbladder Cancer
BRAF L485W
Gallbladder Cancer